Drugs / SPC4955
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01365663 | May → Oct 2011 | hyperlipidemia | Santaris Pharma A/S | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SPC4955 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01365663 ↗ |
| Route | Subcutaneous | “3 Weekly SC injections” NCT01365663 ↗ |